2012-04-26-世界卫生组织-Fifth_report_of_the_Strategic_and_Technical_Advisory_Group_for_Neglected_Tropical_Diseases_STAG-NTDs_54页_1mb

Summary of WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) Meeting

The meeting of the STAG-NTD was held at WHO headquarters in Geneva on April 24-25, 2012. Key topics included reviewing progress in controlling neglected tropical diseases (NTDs), discussing preventive chemotherapy, monitoring tools, drug efficacy, eradication strategies, capacity building, and future recommendations.

Key Discussions and Findings

• Preventive Chemotherapy Rollout: Emphasized the need for efficient implementation, including integrating planning, monitoring, and scaling up interventions. A scorecard was endorsed to track progress in preventive chemotherapy for NTDs like lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases, and trachoma.
• Drug Efficacy and Safety: Standardized procedures were developed for monitoring drug performance, including reviewing resistance markers and pilot testing new diagnostics. Collaboration with partners like Merck KGaA and Joint Venture Partners was noted, with commitments to increase donations.
• Definitions for Control/Eradication: Elimination, eradication, and control were defined clearly to standardize terminology. Eradication means reducing worldwide incidence to zero, elimination for a specific geographic area, and control reducing incidence to local levels.
• Neglected Zoonotic Diseases (NZDs): Identified six priority NZDs, highlighting the need for integrated veterinary-public health approaches. Surveillance capacity building was recommended for diagnosis and data sharing.
• Monitoring and Evaluation: Tools were improved for measuring program impact, including mapping co-endemic areas, defining post-MDA surveillance, and capacity building for disease-specific monitoring.
• Capacity Building: Training programs were proposed for national NTD managers, focusing on integrated planning, coordination, and programmatic management.
• Dengue Prevention: A global strategy was strongly endorsed to reduce mortality and morbidity by at least 50% and 25%, respectively, by 2020.
• Challenges Addressed: Financial constraints from the global economic downturn impacted funding for NTDs, with WHO coordinating efforts. Data gaps and drug resistance were highlighted, requiring more research and resource allocation.

Recommendations and Action Points

• Ensure preventive chemotherapy is rolled out at scale.
• Implement drug efficacy monitoring as part of routine evaluation.
• Strengthen surveillance and capacity building for NZDs.
• Advance research on diagnostics and resistance markers.
• Develop a global strategy for NTD surveillance and impact assessment.

Outcomes

Achievements from 2011 included eradicating dracunculiasis and scaling up preventive chemotherapy. The roadmap for NTD control was confirmed, with a focus on integrated programs and sustainability. Upcoming events in 2012 include the 65th World Health Assembly and national-level capacity-building activities.